...
首页> 外文期刊>Leukemia >High expression of several tyrosine kinases and activation of the PI3K|[sol]|AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma
【24h】

High expression of several tyrosine kinases and activation of the PI3K|[sol]|AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma

机译:纵隔大B细胞淋巴瘤中几种酪氨酸激酶的高表达和PI3K | [sol] | AKT途径的激活揭示了与霍奇金淋巴瘤的进一步相似性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Mediastinal large B-cell (MBL) and classical Hodgkin lymphoma (HL) have several pathogenic mechanisms in common. As we recently observed aberrant tyrosine kinase (TK) activities in HL, we now analysed also MBL for such activities. Indeed, MBL and HL were the only B-cell lymphomas where elevated cellular phospho-tyrosine contents were typical features. Three TKs, JAK2, RON and TIE1, not expressed in normal B cells, were each expressed in about 30% of MBL cases, and 75% of cases expressed at least one of the TKs. Among the intracellular pathways frequently triggered by TKs, the PI3K/AKT pathway was activated in about 40% of MBLs and essential for survival of MBL cell lines, whereas the RAF/mitogen-activated protein kinase pathway seemed to be inhibited. No activating mutations were detected in the three TKs in MBL cell lines and primary cases. RON and TIE1 were each also expressed in about 35% and JAK2 in about 53% of HL cases. JAK2 genomic gains are frequent in MBL and HL but we observed no strict correlation of JAK2 genomic status with JAK2 protein expression. In conclusion, aberrant TK activities are a further shared pathogenic mechanism of MBL and HL and may be interesting targets for therapeutic intervention.
机译:纵隔大B细胞(MBL)和经典霍奇金淋巴瘤(HL)具有几种共同的致病机制。正如我们最近在HL中观察到异常的酪氨酸激酶(TK)活性一样,我们现在也分析了MBL的此类活性。实际上,MBL和HL是仅有的细胞磷酸酪氨酸含量升高是典型特征的B细胞淋巴瘤。在正常B细胞​​中未表达的三个TK,JAK2,RON和TIE1,分别在大约30%的MBL病例中表达,在75%的病例中表达了至少一种TK。在TKs经常触发的细胞内途径中,PI3K / AKT途径在大约40%的MBL中被激活,对于MBL细胞系的生存至关重要,而RAF /促分裂原激活的蛋白激酶途径似乎被抑制。在MBL细胞系和原发病例的三个TK中未检测到激活突变。 RON和TIE1分别在HL病例中约占35%,JAK2约占53%。在MBL和HL中,JAK2基因组的获得很常见,但我们未发现JAK2基因组状态与JAK2蛋白表达之间存在严格的相关性。总之,异常的TK活性是MBL和HL的另一种共同的致病机制,可能是治疗干预的有趣靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号